Biogen shares soar on Alzheimer's drug candidate Biogen released new data on its drug lecanemab which showed promising signs of potentially slowing down the progression of Alzheimer's disease. More on this For more news, please go to FoxBusiness.com and watch Fox Business Network.

More NewslettersUnsubscribePrivacy PolicyContact Us ©2022 Fox News Network, LLC. 1211 Avenue of the Americas, New York, NY, 10036. All Rights Reserved. Privacy Policy Fox Business never sends unsolicited email. You received this email because you requested a subscription to Fox Business Breaking News Alerts from FoxBusiness.com